Mo Dimbil
Impact in
- Toxicology top 2%
- Pharmacovigilance and Adverse Drug Reactions
-
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
Papers in
-
- Pharmacovigilance and Adverse Drug Reactions 4
- Surgery 1
- Lipoproteins and Cardiovascular Health 1
- Co-authors
- Keith B. Hoffman (7 shared papers)Nicholas P. Tatonetti (4 shared papers)Beatrice A. Golomb (1 shared paper)Christina N. Kraus (1 shared paper)Matthew S. Duprey (1 shared paper)Nada S. Al‐Qadheeb (1 shared paper)Christopher Madias (1 shared paper)Jonathan Weinstock (1 shared paper)
- Journals
- Drug Safety (4 papers)Journal of Managed Care & Specialty Pharmacy (1 paper)PLoS ONE (1 paper)Drugs - Real World Outcomes (1 paper)
- Partner nations
- United States
In The Last Decade
Mo Dimbil
7 papers receiving 472 citations
Peers
Comparison fields: 5 of 93
- Toxicology 107
- Rheumatology 55
- Pharmacology 27
- Hematology 30
- Internal Medicine 6
Countries citing papers authored by Mo Dimbil
This map shows the geographic impact of Mo Dimbil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mo Dimbil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mo Dimbil more than expected).
Fields of papers citing papers by Mo Dimbil
This network shows the impact of papers produced by Mo Dimbil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mo Dimbil. The network helps show where Mo Dimbil may publish in the future.
Co-authors
The 10 scholars most cited alongside Mo Dimbil, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 142 | |
| 2 | 2017 | 116 | |
| 3 | 2012 | 98 | |
| 4 | 2014 | 91 | |
| 5 | 2016 | 28 | |
| 6 | 2019 | 8 | |
| 7 | 2015 | 5 |
About Mo Dimbil
Mo Dimbil is a scholar working on Toxicology, Surgery, Infectious Diseases, Organic Chemistry and Communication, having authored 7 papers that have together received 488 indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (4 papers) and Lipoproteins and Cardiovascular Health (1 paper). The work is most often cited by research in Toxicology (107 citations), Rheumatology (55 citations), Pharmacology (27 citations), Hematology (30 citations) and Internal Medicine (6 citations). Mo Dimbil has collaborated with scholars based in United States. Frequent co-authors include Keith B. Hoffman, Nicholas P. Tatonetti, Beatrice A. Golomb, Christina N. Kraus, Matthew S. Duprey, Nada S. Al‐Qadheeb, Christopher Madias, Jonathan Weinstock, J. Nicholas O’Donnell and John W. Devlin. Their work appears in journals such as Drug Safety, Journal of Managed Care & Specialty Pharmacy, PLoS ONE and Drugs - Real World Outcomes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.